Search Results

Amgen abandons development work on clotting drug.

• Authors : Rundle, Rhonda L.

Subjects: AMGEN Inc.; EXPERIMENTAL pharmacology; MEGAKARYOCYTES

• Source: Wall Street Journal - Eastern Edition. 09/14/98, Vol. 232 Issue 52, pB8. 0p.

Record details

Lupus Foundation of America and Lupus Canada Award Grant for Critical Study Examining Platelet Biology as a Potential Lupus Treatment Pathway

• Authors : PR Newswire

Subjects: District of Columbia

• Source: PR Newswire US. 08/31/2022.

Record details

Swedish Orphan Biovitrum starts phase 3 study of avatrombopag in children with ITP

• Source: Global Banking News (GBN). 03/12/2021.

Record details

Swedish Orphan Biovitrum starts phase 3 study of avatrombopag in children with ITP

• Source: Nordic Business Report (M2). 03/12/2021.

Record details

Swedish Orphan Biovitrum starts phase 3 study of avatrombopag in children with ITP

• Source: EquityBites (M2). 03/12/2021.

Record details

Foghorn Therapeutics Inc. to Review Key Programs Call - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 04/09/2024.

Record details

Foghorn Therapeutics Inc. to Review Key Programs Call - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 04/09/2024.

Record details

Breakthrough in quest to make artificial blood.

• Authors : Fiona MacRae

• Source: Daily Mail. 4/8/2016, p28. 1p.

Record details

Morphic Holding Inc at JPMorgan Healthcare Conference - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 01/10/2024.

Record details

Keros Therapeutics Inc to Host Conference Call - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 12/11/2023.

Record details